Immunoinflammatory Regulation of Esketamine in Septic Patients

Clinical trial NCT04843982 · RECRUITING

Trial details

NCT number: NCT04843982
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Esketamine Sepsis Inflammatory Response Immunosuppression

Start date: 2021-07-28
Primary completion: 2026-10-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.